NEW YORK (GenomeWeb News) – Privately-held US Genomics has raised $1 million through a sale of equity and debt securities to company executives and directors, and may raise up to $1 million more, according to a filing with the US Securities and Exchange Commission.

The Woburn, Mass.-based firm offers tools used in the extraction of high-grade DNA, tagging, microfluidics, and genomic mapping, for a range of purposes such as diagnostics, biosecurity, and food and drug monitoring.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.

The New York Times reports that evidence linking trauma in one generation to epigenetic effects that influence subsequent generations may be overstated.

ScienceInsider reports that US National Institutes of Health researchers were told in the fall they could not obtain new human fetal tissue.

In PNAS this week: skin pigmentation evolution among KhoeSan, biomarkers for dengue virus progression, and more.